XML 153 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 81,543,000 $ 96,449,000
Restricted cash 1,234,000 1,542,000
Trade receivables, net 2,431,000 0
Marketable securities 395,420,000 290,610,000
Inventories 4,307,000 0
Prepaid expenses and other current assets 11,784,000 14,172,000
Total current assets 496,719,000 402,773,000
Property, plant, and equipment, net 1,939,000 2,261,000
Intangible assets, net 7,375,000 0
Operating lease right-of-use asset 2,803,000 3,040,000
Other assets 78,000 78,000
Total assets 508,914,000 408,152,000
Current liabilities:    
Accounts payable 8,666,000 7,353,000
Accrued liabilities 27,797,000 25,540,000
Operating lease liability 639,000 433,000
Total current liabilities 37,102,000 33,326,000
Operating lease liability, noncurrent 4,285,000 4,774,000
Long-term debt, net 196,753,000 72,350,000
Other long-term liabilities 0 25,000
Total liabilities 238,140,000 110,475,000
Commitments and contingencies (Note 7)
Stockholders’ equity:    
Preferred stock, $0.0001 par value; 10,000,000 shares authorized at September 30, 2022 and December 31, 2021; no shares issued and outstanding at September 30, 2022 and December 31, 2021; 0 0
Common stock, $0.0001 par value; 300,000,000 shares authorized at September 30, 2022 and December 31, 2021; 60,927,208 and 50,345,755 shares issued at September 30, 2022 and December 31, 2021, respectively; 60,908,641 and 50,255,614 shares outstanding at September 30, 2022 and December 31, 2021, respectively 6,000 5,000
Additional paid-in capital 920,109,000 706,233,000
Accumulated other comprehensive loss (1,596,000) (255,000)
Accumulated deficit (647,745,000) (408,306,000)
Total stockholders’ equity 270,774,000 297,677,000
Total liabilities and stockholders’ equity $ 508,914,000 $ 408,152,000